$PAHC
PHIBRO ANIMAL HEALTH CORP

2020 Q4 Form 10-Q Financial Statement

#000110465921011566 Filed on February 03, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $206.1M $214.0M
YoY Change -3.67% -1.92%
Cost Of Revenue $137.9M $144.9M
YoY Change -4.85% -3.14%
Gross Profit $68.27M $69.10M
YoY Change -1.21% 0.73%
Gross Profit Margin 33.11% 32.29%
Selling, General & Admin $48.38M $49.50M
YoY Change -2.26% 11.48%
% of Gross Profit 70.86% 71.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.088M $8.148M
YoY Change -0.74% 19.12%
% of Gross Profit 11.85% 11.79%
Operating Expenses $48.38M $49.50M
YoY Change -2.26% 11.48%
Operating Profit $19.89M $19.61M
YoY Change 1.43% -18.97%
Interest Expense $3.476M $3.937M
YoY Change -11.71% -170.3%
% of Operating Profit 17.48% 20.08%
Other Income/Expense, Net -$100.0K
YoY Change
Pretax Income $16.05M $16.90M
YoY Change -4.99% -15.95%
Income Tax $3.251M $5.001M
% Of Pretax Income 20.25% 29.6%
Net Earnings $12.80M $11.89M
YoY Change 7.63% -19.09%
Net Earnings / Revenue 6.21% 5.56%
Basic Earnings Per Share $0.32 $0.29
Diluted Earnings Per Share $0.32 $0.29
COMMON SHARES
Basic Shares Outstanding 40.45M 40.45M
Diluted Shares Outstanding 40.50M 40.50M

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.50M $75.20M
YoY Change 26.99% -6.35%
Cash & Equivalents $34.53M $26.18M
Short-Term Investments $61.00M $49.00M
Other Short-Term Assets $42.28M $29.40M
YoY Change 43.8% 24.58%
Inventory $213.3M $193.5M
Prepaid Expenses
Receivables $126.0M $147.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $477.2M $445.5M
YoY Change 7.11% 1.0%
LONG-TERM ASSETS
Property, Plant & Equipment $150.3M $167.8M
YoY Change -10.41% 26.45%
Goodwill $52.68M
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.638M $10.40M
YoY Change -55.4%
Other Assets $56.84M $36.30M
YoY Change 56.58% -20.39%
Total Long-Term Assets $326.5M $342.8M
YoY Change -4.76% 33.8%
TOTAL ASSETS
Total Short-Term Assets $477.2M $445.5M
Total Long-Term Assets $326.5M $342.8M
Total Assets $803.7M $788.3M
YoY Change 1.95% 13.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.31M $58.30M
YoY Change 8.59% -10.45%
Accrued Expenses $81.72M $44.50M
YoY Change 83.64% 54.51%
Deferred Revenue $1.868M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $21.90M $15.60M
YoY Change 40.38% 23.81%
Total Short-Term Liabilities $166.9M $147.1M
YoY Change 13.46% 8.32%
LONG-TERM LIABILITIES
Long-Term Debt $364.9M $357.4M
YoY Change 2.1% 14.66%
Other Long-Term Liabilities $58.48M $56.90M
YoY Change 2.78% 27.87%
Total Long-Term Liabilities $58.48M $414.3M
YoY Change -85.88% 16.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.9M $147.1M
Total Long-Term Liabilities $58.48M $414.3M
Total Liabilities $590.3M $570.9M
YoY Change 3.4% 16.01%
SHAREHOLDERS EQUITY
Retained Earnings $198.5M
YoY Change
Common Stock $136.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $213.3M $217.4M
YoY Change
Total Liabilities & Shareholders Equity $803.7M $788.3M
YoY Change 1.95% 13.05%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $12.80M $11.89M
YoY Change 7.63% -19.09%
Depreciation, Depletion And Amortization $8.088M $8.148M
YoY Change -0.74% 19.12%
Cash From Operating Activities $26.91M $32.09M
YoY Change -16.14% 108.92%
INVESTING ACTIVITIES
Capital Expenditures -$7.320M -$8.440M
YoY Change -13.27% 39.04%
Acquisitions
YoY Change
Other Investing Activities -$300.0K -$25.73M
YoY Change -98.83% -2094.57%
Cash From Investing Activities -$7.620M -$34.18M
YoY Change -77.71% 615.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.54M -27.00M
YoY Change -38.74% 455.56%
NET CHANGE
Cash From Operating Activities 26.91M 32.09M
Cash From Investing Activities -7.620M -34.18M
Cash From Financing Activities -16.54M -27.00M
Net Change In Cash 2.750M -29.09M
YoY Change -109.45% -608.57%
FREE CASH FLOW
Cash From Operating Activities $26.91M $32.09M
Capital Expenditures -$7.320M -$8.440M
Free Cash Flow $34.23M $40.53M
YoY Change -15.54% 89.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001069899
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
dei Entity Registrant Name
EntityRegistrantName
PHIBRO ANIMAL HEALTH CORP
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2022-09-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36410
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard, Suite 21
dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
329-7300
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
PAHC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 us-gaap Revenues
Revenues
206149000
CY2019Q4 us-gaap Revenues
Revenues
214012000
us-gaap Revenues
Revenues
401343000
us-gaap Revenues
Revenues
403732000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137884000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
144908000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268959000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
276965000
CY2020Q4 us-gaap Gross Profit
GrossProfit
68265000
CY2019Q4 us-gaap Gross Profit
GrossProfit
69104000
us-gaap Gross Profit
GrossProfit
132384000
us-gaap Gross Profit
GrossProfit
126767000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48375000
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49495000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96806000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97011000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19890000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19609000
us-gaap Operating Income Loss
OperatingIncomeLoss
35578000
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-624000
CY2019Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
718000
us-gaap Operating Income Loss
OperatingIncomeLoss
29756000
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3214000
CY2019Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3432000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6024000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6786000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3007000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2503000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16052000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16895000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32561000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20467000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3251000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5001000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7458000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6058000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
11894000
us-gaap Net Income Loss
NetIncomeLoss
25103000
us-gaap Net Income Loss
NetIncomeLoss
14409000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
11894000
us-gaap Net Income Loss
NetIncomeLoss
25103000
us-gaap Net Income Loss
NetIncomeLoss
14409000
CY2020Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
3729000
CY2019Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
1080000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
4818000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-4000
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9500000
CY2019Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
2203000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
4777000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4620000
CY2020Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-137000
CY2019Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-138000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-272000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-258000
CY2020Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
966000
CY2019Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
303000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1272000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
63000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12400000
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3118000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8595000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4429000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15012000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33698000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9980000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34534000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36343000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
61000000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
55000000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126026000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126522000
CY2020Q4 us-gaap Inventory Net
InventoryNet
213331000
CY2020Q2 us-gaap Inventory Net
InventoryNet
196659000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42276000
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
37313000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
477167000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
451837000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150337000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148109000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66630000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70997000
CY2020Q4 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56838000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60478000
CY2020Q4 us-gaap Assets
Assets
803651000
CY2020Q2 us-gaap Assets
Assets
784100000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21875000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18750000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63306000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
66091000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
81722000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72397000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
166903000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
157238000
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
178000000
CY2020Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
169000000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
186943000
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
199257000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58483000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70401000
CY2020Q4 us-gaap Liabilities
Liabilities
590329000
CY2020Q2 us-gaap Liabilities
Liabilities
595896000
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136654000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135525000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
198454000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
183060000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121790000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130385000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
213322000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
803651000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
784100000
us-gaap Net Income Loss
NetIncomeLoss
25103000
us-gaap Net Income Loss
NetIncomeLoss
14409000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16124000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15929000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
441000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
442000
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
pahc Acquisition Related Items
AcquisitionRelatedItems
0
pahc Acquisition Related Items
AcquisitionRelatedItems
412000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-201000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-565000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7174000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
132000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-258000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-374000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2633000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12906000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10514000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3412000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1327000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2300000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-97000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1395000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-285000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14108000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2327000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1992000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28611000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28521000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31000000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
25000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
25000000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14738000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16115000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
54549000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
521000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1045000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21259000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96709000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
76000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
155000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
67000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
102000000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-9375000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6361000
us-gaap Payments Of Dividends
PaymentsOfDividends
9709000
us-gaap Payments Of Dividends
PaymentsOfDividends
9709000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10084000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36930000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
923000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-135000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1809000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31393000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36343000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57573000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34534000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26180000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8497000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q3 us-gaap Dividends
Dividends
4854000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
192412000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q4 us-gaap Dividends
Dividends
4855000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
213322000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
216015000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5032000
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q3 us-gaap Dividends
Dividends
4854000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
206694000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15012000
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q4 us-gaap Dividends
Dividends
4855000
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
217415000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">1. Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, dairy and beef cattle, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three and six months ended December 31, 2020 and 2019, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the “Annual Report”), filed with the Securities and Exchange Commission on August 26, 2020 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2020, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, supplies are constrained and distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
12801000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
11894000
us-gaap Net Income Loss
NetIncomeLoss
25103000
us-gaap Net Income Loss
NetIncomeLoss
14409000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
CY2019Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2020Q4 us-gaap Revenues
Revenues
206149000
CY2019Q4 us-gaap Revenues
Revenues
214012000
us-gaap Revenues
Revenues
401343000
us-gaap Revenues
Revenues
403732000
CY2020Q4 us-gaap Revenues
Revenues
206149000
CY2019Q4 us-gaap Revenues
Revenues
214012000
us-gaap Revenues
Revenues
401343000
us-gaap Revenues
Revenues
403732000
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
4729000
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
4570000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1868000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1109000
CY2020Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
220000
CY2019Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
221000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
441000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
442000
CY2020Q4 us-gaap Interest Expense Other
InterestExpenseOther
59000
CY2019Q4 us-gaap Interest Expense Other
InterestExpenseOther
155000
us-gaap Interest Expense Other
InterestExpenseOther
126000
us-gaap Interest Expense Other
InterestExpenseOther
288000
CY2020Q4 us-gaap Interest Expense
InterestExpense
3476000
CY2019Q4 us-gaap Interest Expense
InterestExpense
3937000
us-gaap Interest Expense
InterestExpense
6585000
us-gaap Interest Expense
InterestExpense
7770000
CY2020Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
262000
CY2019Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
505000
us-gaap Interest And Other Income
InterestAndOtherIncome
561000
us-gaap Interest And Other Income
InterestAndOtherIncome
984000
CY2020Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3214000
CY2019Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3432000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6024000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6786000
CY2020Q4 us-gaap Depreciation
Depreciation
5885000
CY2019Q4 us-gaap Depreciation
Depreciation
5840000
us-gaap Depreciation
Depreciation
11716000
us-gaap Depreciation
Depreciation
11571000
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2203000
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2296000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4408000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4334000
CY2019Q4 pahc Amortization Of Other Assets
AmortizationOfOtherAssets
12000
pahc Amortization Of Other Assets
AmortizationOfOtherAssets
0
pahc Amortization Of Other Assets
AmortizationOfOtherAssets
24000
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8088000
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8148000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16124000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15929000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71070000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73837000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11636000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8881000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
130625000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
113941000
CY2020Q4 us-gaap Inventory Net
InventoryNet
213331000
CY2020Q2 us-gaap Inventory Net
InventoryNet
196659000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2019Q2 us-gaap Goodwill
Goodwill
27348000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25331000
CY2020Q4 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22827000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22873000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10382000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11430000
CY2020Q4 us-gaap Deposits Assets
DepositsAssets
5439000
CY2020Q2 us-gaap Deposits Assets
DepositsAssets
5158000
CY2020Q4 pahc Insurance Investment
InsuranceInvestment
5891000
CY2020Q2 pahc Insurance Investment
InsuranceInvestment
5801000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4638000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4219000
CY2020Q4 us-gaap Business Combination Indemnification Assets Amount As Of Acquisition Date
BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
0
CY2020Q2 us-gaap Business Combination Indemnification Assets Amount As Of Acquisition Date
BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
3000000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
766000
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1021000
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
6895000
CY2020Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
6976000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56838000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60478000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29115000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25825000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7075000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6439000
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5570000
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5782000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5848000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5766000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4217000
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3821000
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4952000
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5757000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4840000
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1535000
CY2020Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2314000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1299000
CY2020Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1272000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17271000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15421000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
81722000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72397000
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2860000
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Payments For Restructuring
PaymentsForRestructuring
1325000
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
1535000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17076000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17276000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12052000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11680000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3840000
CY2020Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7691000
CY2020Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8331000
CY2020Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8067000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4840000
CY2020Q4 pahc International Retirement Plans
InternationalRetirementPlans
5664000
CY2020Q2 pahc International Retirement Plans
InternationalRetirementPlans
5499000
CY2020Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
2424000
CY2020Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
3563000
CY2020Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
0
CY2020Q2 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
546000
CY2020Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9096000
CY2020Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
11239000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58483000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70401000
CY2020Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-8630000
CY2020Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-13448000
CY2020Q4 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-98961000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-103738000
CY2020Q4 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
22299000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
22571000
CY2020Q4 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
2052000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
3256000
CY2020Q4 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2020Q2 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2020Q4 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2118000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2050000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121790000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130385000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
209375000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
218750000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
557000
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
743000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
208818000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
218007000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21875000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18750000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
186943000
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
199257000
pahc Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
140
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137884000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
144908000
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3214000
CY2019Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3432000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268959000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
276965000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6024000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6786000
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Assets
Assets
803651000
CY2020Q2 us-gaap Assets
Assets
784100000

Files In Submission

Name View Source Status
0001104659-21-011566-index-headers.html Edgar Link pending
0001104659-21-011566-index.html Edgar Link pending
0001104659-21-011566.txt Edgar Link pending
0001104659-21-011566-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20201231.xsd Edgar Link pending
pahc-20201231x10q.htm Edgar Link pending
pahc-20201231x10q_htm.xml Edgar Link completed
pahc-20201231xex31d1.htm Edgar Link pending
pahc-20201231xex31d2.htm Edgar Link pending
pahc-20201231xex32d1.htm Edgar Link pending
pahc-20201231xex32d2.htm Edgar Link pending
pahc-20201231_cal.xml Edgar Link unprocessable
pahc-20201231_def.xml Edgar Link unprocessable
pahc-20201231_lab.xml Edgar Link unprocessable
pahc-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending